^
BIOMARKER:

BCL2 rearrangement

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
rituximab
Sensitive: C2 – Inclusion Criteria
BCL2 rearrangement
Lymphoma
CAR-T immunotherapy
Resistant: C3 – Early Trials
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
EPOCH-R
Sensitive: C3 – Early Trials